Background A large body of evidence suggests that thyroid hormones (THs) are beneficial
for the treatment of cardiovascular disorders. We have shown that 3 days of triiodo-L …

Background: We have shown that thyroid hormones (THs) are cardioprotective and can be
potentially used as safe therapeutic agents for diabetic cardiomyopathy and permanent …

Aims Severe cardiovascular diseases, such as myocardial infarction or heart failure, can
alter thyroid hormone (TH) secretion and peripheral conversion, leading to low …

Background: Thyroid hormone has a differential action on healthy and ischemic heart.
Triiodothyronine (T3) administration improved postischemic cardiac function while it limited …

There is emerging evidence that treatment with thyroid hormone (TH) can improve
postischemic cardiac function. 3, 5-Diiodothyropropionic acid (DITPA), a TH analog, has …

Background: Beta blockers are standard therapy for myocardial infarction (MI). Preclinical
studies have shown efficacy and safety of thyroid hormone (TH) treatment of cardiovascular …

Background—Patients with congestive heart failure (CHF) often have low serum
triiodothyronine (T3) concentrations. In a rodent model of myocardial infarction-induced CHF …

Reperfusion following a transient ischemic insult has been shown to result in a delayed
recovery of myocardial function. A reduction in plasma triiodothyronine (T3) has been …

Ischemic heart disease (IHD) is the single most common cause of death. New approaches to
enhance myocardial perfusion are needed to improve outcomes for patients with IHD …

Thyroid hormone (TH) appears to have a critical role in cardiac repair after injury beyond its
role in development and metabolism homeostasis. This unique action is due to the fact that …